AstraZeneca president 'would not back pricing deal again'

president AZ Lisa Anson

The UK president of drug giant AstraZeneca has indicated she would not sign up to another deal similar to the current pharmaceutical pricing scheme unless the NHS makes a ‘substantial’ increase of drugs access.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here